Long-term effects of Roluperidone on negative symptoms of schizophrenia
Open Access
- 16 March 2023
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 255, 9-13
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Personal and social adjustment effects of roluperidone in patients with schizophrenia and negative symptoms: Results from an exploratory outcome of a randomized placebo-controlled trialSchizophrenia Research, 2019
- Dopamine dysregulation hypothesis: the common basis for motivational anhedonia in major depressive disorder and schizophrenia?Reviews in the Neurosciences, 2018
- Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in SchizophreniaAmerican Journal of Psychiatry, 2017
- Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte StudiesBiological Psychiatry, 2017
- Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled TrialsSchizophrenia Bulletin, 2014
- Dissecting negative symptoms in schizophrenia: Opportunities for translation into new treatmentsJournal of Psychopharmacology, 2014
- Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatmentEuropean Neuropsychopharmacology, 2014
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of SchizophreniaThe Journal of Clinical Psychiatry, 2012
- The course of schizophrenia: Progressive deterioration, amelioration or both?Schizophrenia Research, 2007
- Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioningActa Psychiatrica Scandinavica, 2000